Sangamo Therapeutics (SGMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SGMO | AMGN | GILD | CELG | BIIB |
| Company | Sangamo Therapeutics | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Biogen Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.4787 | 264.63 | 66.25 | 108.01 | 190.72 |
| High | 0.5291 | 269.38 | 66.83 | 108.59 | 194.52 |
| Low | 0.4701 | 260.68 | 66.16 | 107.27 | 189.44 |
| Last | 0.5115 | 268.93 | 66.76 | 108.24 | 194.38 |
| Change | +0.0264 | +6.18 | +0.60 | +0.11 | +3.86 |
| % Change | +5.44% | +2.35% | +0.91% | +0.10% | +2.03% |
| Volume | 1,039,700 | 3,380,000 | 10,656,899 | 191,230,496 | 1,599,500 |
| 20-Day Average Volume | 2,018,285 | 2,246,420 | 6,455,915 | 16,188,930 | 1,140,990 |
| Previous Close | 0.4851 | 262.75 | 66.16 | 108.13 | 190.52 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.5764 | 272.56 | 69.90 | 108.17 | 205.03 |
| 20-Day Raw Stochastic | 9.10% | 29.59% | 10.79% | 63.25% | 15.51% |
| 20-Day Relative Strength | 40.85% | 43.95% | 31.30% | 64.69% | 32.40% |
| Weighted Alpha | -84.73 | +7.67 | -24.32 | +46.30 | -36.99 |
| Today's Opinion | 56% Sell | 56% Sell | 100% Sell | 100% Buy | 100% Sell |
| Previous Opinion | 56% Sell | 56% Sell | 100% Sell | 100% Buy | 100% Sell |
| Last Month's Opinion | 48% Buy | 8% Sell | 72% Sell | 100% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.87% since 04/12/24 | +0.62% since 04/12/24 | -1.92% since 04/12/24 | -1.97% since 11/13/19 | -1.92% since 04/12/24 |
| Low | 0.4701 on 04/19/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 107.27 on 11/20/19 | 189.44 on 04/19/24 |
| High | 0.5700 on 04/15/24 | 270.93 on 04/15/24 | 68.46 on 04/15/24 | 110.53 on 11/14/19 | 199.53 on 04/15/24 |
| 1-Month | |||||
| %Chg | -33.57% since 03/19/24 | -1.03% since 03/19/24 | -9.06% since 03/19/24 | +5.14% since 10/18/19 | -11.09% since 03/19/24 |
| Low | 0.4701 on 04/19/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 102.40 on 10/21/19 | 189.44 on 04/19/24 |
| High | 0.9782 on 03/21/24 | 288.57 on 03/28/24 | 74.28 on 03/21/24 | 110.70 on 11/13/19 | 221.74 on 03/21/24 |
| 3-Month | |||||
| %Chg | +18.38% since 01/19/24 | -12.63% since 01/19/24 | -23.52% since 01/19/24 | +13.63% since 08/20/19 | -22.24% since 01/19/24 |
| Low | 0.4110 on 01/26/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 93.41 on 08/23/19 | 189.44 on 04/19/24 |
| High | 1.4800 on 02/16/24 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 110.70 on 11/13/19 | 252.17 on 01/22/24 |
| 6-Month | |||||
| %Chg | -3.74% since 10/19/23 | -4.16% since 10/19/23 | -14.89% since 10/19/23 | +14.14% since 05/20/19 | -24.45% since 10/19/23 |
| Low | 0.2911 on 11/13/23 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 89.08 on 07/23/19 | 189.44 on 04/19/24 |
| High | 1.4800 on 02/16/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 268.30 on 01/03/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 86,787 | 140,812,720 | 82,374,304 | 77,035,920 | 27,694,178 |
| Shares Outstanding, K | 178,906 | 535,919 | 1,245,077 | 711,714 | 145,361 |
| Annual Sales | 176,230,000 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 9,835,600,000 |
| Annual Net Income | -257,830,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | 1,161,100,000 |
| Last Quarter Sales | 2,040,000 | 8,196,000,000 | 7,114,000,000 | 4,520,000,000 | 2,386,300,000 |
| Last Quarter Net Income | -60,300,000 | 767,000,000 | 1,429,000,000 | 1,691,000,000 | 249,700,000 |
| 60-Month Beta | 1.39 | 0.58 | 0.19 | 1.41 | -0.02 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.34 on 03/13/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 2.99 on 10/31/19 | 2.95 on 02/13/24 |
| Latest Earnings Date | 05/13/24 | 05/02/24 | 04/25/24 | 10/31/19 | 04/24/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.16 | 9.96 | 10.99 | 13.05 |